BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34727578)

  • 41. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
    Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model.
    Ciurea A; Hunziker L; Zinkernagel RM; Hengartner H
    Immunogenetics; 2001 Apr; 53(3):185-9. PubMed ID: 11398962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression.
    Welsh RM; Oldstone MB
    J Exp Med; 1977 Jun; 145(6):1449-68. PubMed ID: 301173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection.
    Whitmire JK; Slifka MK; Grewal IS; Flavell RA; Ahmed R
    J Virol; 1996 Dec; 70(12):8375-81. PubMed ID: 8970958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.
    Zhang Y; Yan Q; Luo K; He P; Hou R; Zhao X; Wang Q; Yi H; Liang H; Deng Y; Hu F; Li F; Liu X; Feng Y; Li P; Qu L; Chen Z; Pan-Hammarström Q; Feng L; Niu X; Chen L
    J Virol; 2022 Feb; 96(4):e0160021. PubMed ID: 34878902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Focused antibody response in plasma cell-infiltrated non-medullary (NOS) breast cancers.
    Wang Y; Ylera F; Boston M; Kang SG; Kutok JL; Klein-Szanto AJ; Junghans RP
    Breast Cancer Res Treat; 2007 Aug; 104(2):129-44. PubMed ID: 17393302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD8 T cell memory in B cell-deficient mice.
    Asano MS; Ahmed R
    J Exp Med; 1996 May; 183(5):2165-74. PubMed ID: 8642326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-cell STAT3 is required for the maintenance of humoral immunity to LCMV.
    McIlwain DR; Grusdat M; Pozdeev VI; Xu HC; Shinde P; Reardon C; Hao Z; Beyer M; Bergthaler A; Häussinger D; Nolan GP; Lang KS; Lang PA
    Eur J Immunol; 2015 Feb; 45(2):418-27. PubMed ID: 25393615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection.
    Buchmeier MJ; Oldstone MB
    J Immunol; 1978 Apr; 120(4):1297-304. PubMed ID: 76662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.
    Wieland A; Shashidharamurthy R; Kamphorst AO; Han JH; Aubert RD; Choudhury BP; Stowell SR; Lee J; Punkosdy GA; Shlomchik MJ; Selvaraj P; Ahmed R
    Immunity; 2015 Feb; 42(2):367-378. PubMed ID: 25680276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and application of ELISA for the detection of IgG antibodies to lymphocytic choriomeningitis virus.
    Lapošová K; Lukáčiková Ľ; Ovečková I; Pastoreková S; Rosocha J; Kuba D; Beňa Ľ; Tomášková J
    Acta Virol; 2016 Jun; 60(2):143-50. PubMed ID: 27265463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.
    Hangartner L; Zellweger RM; Giobbi M; Weber J; Eschli B; McCoy KD; Harris N; Recher M; Zinkernagel RM; Hengartner H
    J Exp Med; 2006 Aug; 203(8):2033-42. PubMed ID: 16880253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
    Ahmed R; Salmi A; Butler LD; Chiller JM; Oldstone MB
    J Exp Med; 1984 Aug; 160(2):521-40. PubMed ID: 6332167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.
    Wright KE; Buchmeier MJ
    J Virol; 1991 Jun; 65(6):3001-6. PubMed ID: 1709692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
    Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
    J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of diabetes in BB rats by virus infection. II. Effect of virus infection on the immune response to non-viral and viral antigens.
    Shyp S; Tishon A; Oldstone MB
    Immunology; 1990 Apr; 69(4):501-7. PubMed ID: 2335372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.
    Abraham RS; Manske MK; Zuckerman NS; Sohni A; Edelman H; Shahaf G; Timm MM; Dispenzieri A; Gertz MA; Mehr R
    J Clin Immunol; 2007 Jan; 27(1):69-87. PubMed ID: 17192818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.